Diabetes and Impaired Fracture Healing: A Narrative Review of Recent Literature

被引:30
作者
Tanios, Mina [1 ]
Brickman, Bradley [2 ]
Cage, Emily [1 ]
Abbas, Kassem [2 ]
Smith, Cody [1 ]
Atallah, Marina [2 ]
Baroi, Sudipta [1 ]
Lecka-Czernik, Beata [1 ,3 ]
机构
[1] Univ Toledo, Coll Med & Life Sci, Dept Orthoped Surg, 2801 W Bancroft St, Toledo, OH 43606 USA
[2] Univ Toledo, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA
[3] Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res, 2801 W Bancroft St, Toledo, OH 43606 USA
关键词
Diabetes mellitus; Fracture healing; Bone fractures; Advanced glycation end products; Osteoblast; Osteoclast; GLYCATION END-PRODUCTS; OXIDATIVE STRESS; BONE-FORMATION; VERTEBRAL FRACTURES; SIGNALING PATHWAYS; HIGH GLUCOSE; RISK; TYPE-1; DIFFERENTIATION; EXPRESSION;
D O I
10.1007/s11914-022-00740-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of the Review Diabetes mellitus is a chronic metabolic disorder commonly encountered in orthopedic patients. Both type 1 and type 2 diabetes mellitus increase fracture risk and impair fracture healing. This review examines complex etiology of impaired fracture healing in diabetes. Recent Findings Recent findings point to several mechanisms leading to orthopedic complications in diabetes. Hyperglycemia and chronic inflammation lead to increased formation of advanced glycation end products and generation of reactive oxygen species, which in turn contribute to the disruption in osteoblast and osteoclast balance leading to decreased bone formation and heightening the risk of nonunion or delayed union as well as impaired fracture healing. The mechanisms attributing to this imbalance is secondary to an increase in pro-inflammatory mediators leading to premature resorption of callus cartilage and impaired bone formation due to compromised osteoblast differentiation and their apoptosis. Other mechanisms include disruption in the bone's microenvironment supporting different stages of healing process including hematoma and callus formation, and their resolution during bone remodeling phase. Complications of diabetes including peripheral neuropathy and peripheral vascular disease also contribute to the impairment of fracture healing. Certain diabetic drugs may have adverse effects on fracture healing. The pathophysiology of impaired fracture healing in diabetic patients is complex. This review provides an update of the most recent findings on how key mediators of bone healing are affected in diabetes.
引用
收藏
页码:229 / 239
页数:11
相关论文
共 114 条
  • [91] Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing
    Sun, Naidi
    Ning, Bo
    Hansson, Kenny M.
    Bruce, Anthony C.
    Seaman, Scott A.
    Zhang, Chenchu
    Rikard, Michaela
    DeRosa, Christopher A.
    Fraser, Cassandra L.
    Wagberg, Maria
    Fritsche-Danielson, Regina
    Wikstrom, Johannes
    Chien, Kenneth R.
    Lundahl, Anna
    Holtta, Mikko
    Carlsson, Leif G.
    Peirce, Shayn M.
    Hu, Song
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [92] Diabetes and bone health: latest evidence and clinical implications
    Sundararaghavan, Vikram
    Mazur, Matthew M.
    Evans, Brad
    Liu, Jiayong
    Ebraheim, Nabil A.
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2017, 9 (03) : 67 - 74
  • [93] Altered microRNA profile during fracture healing in rats with diabetes
    Takahara, Shunsuke
    Lee, Sang Yang
    Iwakura, Takashi
    Oe, Keisuke
    Fukui, Tomoaki
    Okumachi, Etsuko
    Arakura, Michio
    Sakai, Yoshitada
    Matsumoto, Tomoyuki
    Matsushita, Takehiko
    Kuroda, Ryosuke
    Niikura, Takahiro
    [J]. JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2020, 15 (01)
  • [94] Advanced Glycation End Products Subspecies-Selectively Induce Adhesion Molecule Expression and Cytokine Production in Human Peripheral Blood Mononuclear Cells
    Takahashi, Hideo Kohka
    Mori, Shuji
    Wake, Hidenori
    Liu, Keyue
    Yoshino, Tadashi
    Ohashi, Katsuhisa
    Tanaka, Noriaki
    Shikata, Kenichi
    Makino, Hirofumi
    Nishibori, Masahiro
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (01) : 89 - 98
  • [95] Involvement of Toxic AGEs (TAGE) in the Pathogenesis of Diabetic Vascular Complications and Alzheimer's Disease
    Takeuchi, Masayoshi
    Yamagishi, Sho-ichi
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (04) : 845 - 858
  • [96] Glycolaldehyde-modified advanced glycation end-products inhibit differentiation of human monocytes into osteoclasts via upregulation of IL-10
    Tanaka, Kenichi
    Yamagata, Kaoru
    Kubo, Satoshi
    Nakayamada, Shingo
    Sakata, Kei
    Matsui, Takanori
    Yamagishi, Sho-ichi
    Okada, Yosuke
    Tanaka, Yoshiya
    [J]. BONE, 2019, 128
  • [97] The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear Factor-κB, and by 17β-estradiol through Sp-1 in human vascular endothelial cells
    Tanaka, N
    Yonekura, H
    Yamagishi, S
    Fujimori, H
    Yamamoto, Y
    Yamamoto, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) : 25781 - 25790
  • [98] Mechanical regulation of signaling pathways in bone
    Thompson, William R.
    Rubin, Clinton T.
    Rubin, Janet
    [J]. GENE, 2012, 503 (02) : 179 - 193
  • [99] Collagen cross-linking influences osteoblastic differentiation
    Turecek, C.
    Fratzl-Zelman, N.
    Rumpler, M.
    Buchinger, B.
    Spitzer, S.
    Zoehrer, R.
    Durchschlag, E.
    Klaushofer, K.
    Paschalis, E. P.
    Varga, F.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (05) : 392 - 400
  • [100] Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis
    Vestergaard, P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 (04) : 427 - 444